News

C.W. Downer & Co. Assists InterHealth Nutraceuticals, Inc. with Sale to Kainos Capital

BOSTON, January 8, 2014 – C.W. Downer & Co., a leading global middle-market investment bank, is pleased to announce that InterHealth Nutraceuticals, Inc. has been acquired by Kainos Capital LLC of Dallas, Texas. The deal closed on November 26, 2013 and the financial terms were not disclosed.

Founded in 1987, InterHealth is the leading provider of branded proprietary nutritional ingredients that are validated through extensive scientific research and clinical studies. InterHealth’s ingredient brands include Super CitriMax®, UC-II®, ChromeMate® and L-OptiZinc®. These ingredient brands are utilized in the production of dietary and nutritional supplements, functional foods and beverages and cosmetic products. InterHealth’s ingredients are used in over 600 nutritional products globally, and its client list includes many of the world’s best-known global manufacturers and distributors of nutritional products, including NBTY, Pharmavite, Glanbia, Nature’s Way, NOW Foods, Coca Cola, Schiff, Life Extension, GNC and TwinLab.

Kainos Capital is a middle market private equity firm that focuses on food and nutrition investments. Kainos’s current portfolio companies in the food and nutrition sector include Earthbound Foods, a company specializing in organic vegetables, fruits and salads, and Milk Specialties Global, a producer of whey-based nutritional products, and Sturm Foods, a producer of dry-mix products sold to retail and foodservice channels. The acquisition of InterHealth will provide Kainos with a strong platform in the branded nutritional ingredients market and represents its first acquisition executed through its latest fund.

“InterHealth’s unique combination of scientific expertise, proprietary brands and superior marketing strategies have driven exceptional performance,” said Joseph Downing, Managing Director at C.W. Downer & Co. “The Company has grown at a rate in excess of 20% annually since 2010 and its superior products, strong customer relationships and dedicated management team will support continued growth in the future. We believe that Kainos Capital will be the perfect partner to assist InterHealth in further accelerating its growth and driving expansion into new markets,” he concluded.

The C.W. Downer & Co. team assisting InterHealth with the sale included Mr. Downing (Managing Director & Partner), Greg Fanikos (Director), Josh Garver (Vice President) and Chris DiPietro (Associate).

About C.W. Downer & Co.

C.W. Downer & Co. is an independent, global investment bank offering middle-market clients a high level of personal attention coupled with 39 years of international execution experience. We provide insight, not just information. We generate value, not just transactions. With nine fully integrated offices on four continents, we consistently identify the most appropriate strategic buyer and uncover “hidden” acquisition targets. C.W. Downer & Co. delivers the reach of a bulge-bracket investment bank with the senior level focus of a boutique. For more information, visit http://www.cwdowner.com.

For Further Information:

Joseph Downing, Managing Director & Partner
This email address is being protected from spambots. You need JavaScript enabled to view it.

Gregory Fanikos, Director
This email address is being protected from spambots. You need JavaScript enabled to view it.
C.W. Downer & Co.
+1 617 482 6200

Back to Previous

© 2015 by C.W. Downer & Co.

Downer & Company (d/b/a C.W. Downer & Co.) is a fully registered broker/dealer
and a member of the Financial Industry Regulatory Authority (FINRA).